key: cord-0852806-7y3x17oz
authors: Niño, Michael D.; Hearne, Brittany N.; Cai, Tianji
title: Trajectories of COVID-19 vaccine intentions among U.S. adults: The role of race and ethnicity
date: 2021-05-27
journal: SSM Popul Health
DOI: 10.1016/j.ssmph.2021.100824
sha: 3784b86eedbbaa7c3aca296850b45fddffdcd6a6
doc_id: 852806
cord_uid: 7y3x17oz

Research examining whether intentions to get a COVID-19 vaccine change over time is scarce. Moreover, the deep and pervasive history of medical racism in the U.S. has created a context in which some racial and ethnic groups exhibit greater levels of COVID-19 vaccine hesitancy; yet few researchers have attempted to determine whether these patterns persist with time. The purpose of this study was twofold: (a.) assess the role of time in COVID-19 vaccine intentions from April 2020 to January 2021, and (b.) examine whether race and ethnicity shape COVID-19 vaccine intention trajectories. Data were drawn from 9 waves of the Understanding America Study (n = 5023), a national probability panel study of U.S. adults. Multilevel logistic regression models were used to assess overall COVID-19 vaccine intention trajectories and trajectories by race and ethnicity. Results demonstrate intentions to get a COVID-19 vaccine significantly decreased from April 2020 to November 2020, but by January 2021, intentions to get a COVID-19 vaccine slightly increased. Findings also show trajectories significantly differed by racial and ethnic background. Asian/Pacific Islanders had the highest probability of likely getting a COVID-19 vaccine at baseline, followed by Whites and Latina/os. Black Americans exhibited the lowest probability of likely getting vaccinated, and, in most cases, the gap between Black Americans and other racial groups grew over time. Key findings from this study demonstrate that, among U.S. adults, time and race and ethnicity play significant roles in COVID-19 vaccine intentions. Understanding the role of time and race and racism in shaping COVID-19 vaccine intention trajectories can help government agencies and public health experts tasked with administrating vaccines better understand disparities in vaccine uptake.

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the novel coronavirus that causes COVID-19 disease, has quickly spread throughout the globe. By late January 2021, more than 100 million cases and approximately 2.1 million COVID-19 related deaths have been reported worldwide. The United States has been particularly impacted by the current pandemic, recording more than 25 million cases and 423,000 COVID-19 related deaths by late January 2021. With no clear signs of abatement, scholars argue that the development, distribution, and administration of vaccines will be the most effective approach to addressing the COVID-19 pandemic (Cory et al., 2020; Shin et al., 2020) .

Safe, effective, and accessible vaccines are foundational to eradicating or significantly reducing morbidity and mortality associated with a range of infectious diseases (Orenstein and Ahmed, 2017) , including the elimination of smallpox and continued reduction of polio cases, tetanus, and measles (Serdobova and Kieny, 2006) . Several COVID-19 vaccines are currently under development, two of which received emergency use authorization by the Food and Drug Administration (FDA) in December 2020. While safety, efficacy, and dissemination of vaccines are critical to the goal of reducing morbidity and mortality associated with COVID-19, an equally important area is vaccine acceptance and uptake. Without widespread acceptance and uptake of COVID-19 vaccines, the goal of herd immunity will be difficult to achieve, leading to the further spread of the novel coronavirus. Scholars argue that approximately 70 percent (69.6%) of the U.S. population needs to have protective immunity from SARS-CoV-2 either through prior infections or vaccinations to reach herd immunity (Kwok et al., 2020) . Herd immunity is essential, given that it not only provides direct protection to the immunized but also indirectly protects those who are potentially unable to receive COVID-19 vaccinations, such as young children and the immunocompromised (Randolph and Barreiro, 2020) .

A significant barrier to reaching herd immunity is vaccine hesitancy, which is defined as the refusal or delay in acceptance of a safe and effective vaccine, despite widespread availability (MacDonald, 2020) . In recent years, vaccine hesitancy has increased substantially across the globe (de Figueiredo et al., 2020) and has contributed to recent preventable infectious disease outbreaks, such as the reemergence of measles in the U.S. in 2019 (Hotez et al., 2020; Sarkar et al., 2019) . The prevalence of vaccine hesitancy and the reemergence of preventable infectious diseases, not only in the U.S. but globally, has become such a concern that the World Health J o u r n a l P r e -p r o o f Organization (WHO) formally named vaccine hesitancy a top ten threat to global health in 2019 (WHO, 2019) .

Given the significant challenge vaccine hesitancy poses to herd immunity, an emerging body of research has attempted to better understand COVID-19 vaccine intentions in the U.S.

More specifically, scholars have focused on identifying structural and cultural factors associated with intentions to receive COVID-19 vaccines. One of the most consistent predictors of vaccine intentions within this small but growing body of research is race and ethnicity. Across a number of studies, scholars find Black Americans show greater hesitancy to receive COVID-19 vaccines (Carpiano, 2020; Fisher et al., 2020; Reiter et al., 2020) , which aligns with broader bodies of work on vaccine hesitancy Jamison et al., 2019; Quinn et al., 2017) .

Americans and other racial and ethnic groups, few properly contextualize the role medical racism has played in these observed patterns (Jaiswal and Halkitis, 2019; Jamison et al., 2019) .

Numerous studies find medical racism has led to deep distrust of medical institutions within Black communities, shaping how Black Americans perceive and engage with medical research (Evans and Hargittai, 2020) , physicians (Hagiwara et al., 2016) , and vaccines (Freimuth et al., 2016; Harris et al., 2006) . The Tuskegee Syphilis Study is the most notable example of medical racism in the U.S. and remains a part of collective memory among Black Americans (Fraizier, 2020) . In 1932, the U.S. Public Health Service, in concert with the Tuskegee Institute, conducted an experiment designed to observe untreated syphilis in Black men. Participants were told they were being treated for "bad blood" and went untreated for syphilis for 40 years, well after effective treatments were available.

Contemporary research also shows that the legacies of medical racism continue to impact access and quality of care for Black Americans. Black patients are less likely to receive effective treatments for leading causes of death, including heart disease, stroke, and lung cancer, when compared to their White counterparts (Bach et al., 1999; Fincher et al., 2004; Mayberry et al., 2000; Schulman et al., 1999) . Black women are also three times more likely to die from pregnancy-related complications than other racial groups (Oparah and Bonaparte, 2015) .

Similarly, Black children are twice as likely to die before age 1 compared to White children (CDC, 2019) . Notably, Black families are able to mitigate the risk of infant death by more than half (58%) when Black physicians care for their children (Greenwood et al., 2020) . Taken as a J o u r n a l P r e -p r o o f whole, the historical and contemporary nature of medical racism is a key contributor to observed inequities in vaccine intentions and uptake observed among Black Americans.

While the extant literature has identified important patterns in intention to receive COVID-19 vaccinations, several critical gaps remain. First, to date, little to no research has attempted to investigate whether time shapes COVID-19 vaccine intentions. Prior studies find time plays a significant role in hesitancy to vaccinate. For example, recently developed vaccines receive substantially more resistance from the general public than more established vaccines (Dubé et al., 2013; Larson et al., 2011) . Moreover, when examining vaccine intentions for a myriad of specific infectious diseases, including types of influenza (Holm et al., 2007) and human papillomavirus (Reiter et al., 2013; Thompson et al., 2017) , evidence suggests intention to vaccinate significantly changes over time. For instance, Gidengil and colleagues (2012) find that among a sample of U.S. adults, the intention to receive the H1N1 vaccine was the highest during the early months of the pandemic in 2009, but as time progressed, intention to vaccinate steadily decreased, even as infections increased. Gindengil and colleagues argue, as with other rare events, people tended to overestimate the risk of hospitalization and death related to H1N1 at the onset of the pandemic, which led to high intentions to receive an H1N1 vaccine. However, as evidence emerged showing that the risk of mortality was comparable to seasonal influenza, intentions to receive an H1N1 vaccine declined substantially over time. Given that the U.S. continues to report record COVID-19 infections and hospitalizations, understanding whether intentions to receive a COVID-19 vaccine increase, decrease, or remain stable is of vital importance as public health practitioners and policymakers develop COVID-19 distribution and administration plans.

Second, the history of differential medical treatment based on race and ethnicity has created a context in which some racial and ethnic groups are more hesitant to receive vaccines; yet whether these patterns change over time is less known. This is of particular importance given the continued disproportionate impact of COVID-19 on historically marginalized racial and ethnic groups. For instance, Black and Latina/o adults are more likely to become infected; be hospitalized due to severe illness and die from COVID-19 complications when compared to Whites. While Asian Americans do not present an increased risk of death from COVID-19, virologic surveillance data indicate Asian Americans are more likely to become infected and be hospitalized when compared to their White counterparts (CDC, 2020).

Using a large, national longitudinal sample of U.S. adults, we address these critical gaps by first assessing the timing and shape of intentions to receive a COVID-19 vaccine from April 2020 to January 2021. We then model trajectories of vaccine intention by race and ethnicity.

More specifically, we assess whether vaccine intention trajectories vary between Black, Latina/o, Asian/Pacific Islander, and White adults from April 2020 to January 2021. In doing so, we are able to determine whether trajectories by race and ethnicity diverge, remain stable, or converge during one of the most significant public health crises in modern history.

Data for this study were drawn from the Understanding America Study (UAS), a national probability-based panel survey of U.S. adults, managed by the Center for Economic and Social

Research at the University of Southern California. The UAS, which began in 2014, selected panel members using address-based sampling, a sequential sample procedure where a simple random sample is first generated using addresses from the Computerized Delivery Sequence (CDS) file; a file containing every postal address in the U.S. Sequential Importance Sampling (SIS), a type of adaptive sampling, was then used to generate unequal sampling probabilities with the overall goal of moving closer to the general U.S. population. Invitations to participate in UAS surveys are sent via email, and panelists receive approximately $20 for every 30 minutes of survey time. Panelists were also provided with broadband internet and a tablet when needed.

On March 10, 2020, UAS panelists were invited to participate in an ongoing survey related to the COVID-19 pandemic. Approximately 7,000 out of the 9,000 eligible UAS respondents agreed to participate. UAS surveys focused on a range of issues related to the COVID-19 pandemic, including, but not limited to, vaccine intentions, perceived COVID-19 symptoms, protective behaviors, mental health, perceived discrimination, and other social behaviors (e.g., alcohol and drug use). For this study, we draw from 9 Waves of the UAS between April 1, 2020, to January 6, 2021 -all of which capture vaccine intention responses at the time of interview.

COVID-19 vaccine intention was assessed using the following question "how likely are you to get vaccinated for coronavirus once a vaccination is available to the public?" Original response J o u r n a l P r e -p r o o f categories included: (1) very unlikely, (2) somewhat unlikely, (3) somewhat likely, (4) very likely, and (5) unsure. Given that we are interested in changes in COVID-19 vaccine intentions, and to simplify and ease the interpretation of results, we construct a binary measure of COVID-19 vaccine intention: (0) very unlikely/somewhat unlikely/unsure, (1) somewhat likely/very likely. As stated above, COVID-19 vaccine intention was measured repeatedly on the same study participants across all 9 UAS Waves.

Race and ethnicity was measured using a respondent's self-reported racial and ethnic identity. The original race and ethnicity measure included in the UAS captured the following self-reported racial and ethnic identities: Black, Latina/o, Asian/Pacific Islander, and Native

American. Unfortunately, due to small sample sizes across UAS waves, we were unable to keep respondents that self-identified as Native American in the final analytic sample. Furthermore, UAS surveys did not provide opportunities for respondents to select more than one racial and ethnic identity. Therefore, we were unable to identify and include a category for respondents that held more than one racial and/or ethnic identity. Due to these data limitations, our final race and ethnicity measure included categories for Black, Latina/o, Asian/Pacific Islander, and White (reference).

We also include a series of measures that have been shown to play a role in vaccine hesitancy. The measures include gender, age, immigrant generation, work status, marital status, education level, household income, and perceived risk of death from COVID-19. Gender was measured using a dummy variable for male, with female as the reference. Age was measured in years and ranged from ages 18-101. Immigrant generation includes three categories: firstgeneration (foreign-born), second-generation (children of immigrants), and third-generation plus.

Respondents that were born in a foreign country to at least one foreign-born parent were classified as first-generation. Individuals were considered second-generation if they were born in the United States to at least one foreign-born parent. Those born in the United States to parents also born in the United States were considered third-generation plus. Work status is a dummy variable that denotes whether respondents were working or not. Marital status was measured using a dummy variable for married, with not married as the reference. Education level was measured using four dummy variables: less than high school, high school, some college, and bachelor's degree or higher. Annual household income was divided into four categories: less than $5,000-$34,999, $35,000-$59,999, $60,000-$74,999, and greater than or equal to $75,000.

Perceived risk of death from COVID-19 was measured using the following question "if you do get the coronavirus, what is the percent chance you will die from it. Responses for this measure ranged from 0 to 100%.

[ Table 1 about here]

To estimate vaccine intention trajectories from early April 2020 to January 2021, we adopt a multilevel logistic regression model with an individual-level random effect to control for the repeated measurements of respondents. For example, the probability of likely to vaccinate by

is predicted by:

such that = , where represents the estimated slope;

represents the row vector of estimated coefficients and the timing of the corresponding UAS We utilized maximum likelihood estimation to account for missing data under the assumption that non-responses were missing at random.

J o u r n a l P r e -p r o o f

Given that there is a potential loss of information when including the unsure category with responses for very unlikely and somewhat unlikely, we estimated a series of regression models with alternative operations of the COVID-19 vaccine intention measure. In the first series of supplemental models (S1), unsure responses were removed from the final analytic sample, and results produced results that were similar in statistical significance, direction, and magnitude.

The second set of supplemental models (S2) provide estimates for a series of repeated measures multinomial logistic regressions that operationalized COVID-19 vaccine intentions with three categories: (0) unsure, (1) very unlikely/somewhat unlikely, (2) somewhat likely/very likely.

Results from the first model show the probability respondents were unsure of getting a vaccine was low from the onset of the COVID-19 pandemic (<1%) and remained low throughout the duration of this study. When compared to unsure respondents, model 2 shows racial and ethnic groups have statistically indistinguishable rates of change in likely and unlikely to get a COVID-19 vaccine. Taken together, estimates from our sensitivity analysis provide little to no evidence of a meaningful loss of information when including unsure responses with unlikely responses.

[ Table 2 about here] (Guidry et al., 2021; Robinson et al., 2020; Wong et al., 2020) . Results also show vaccine intention is lowest among Black respondents, which remains consistent over time. In contrast, Asian/Pacific Islanders present the highest proportion of likely to get a COVID-19 vaccine among the racial and ethnic groups included in this study.

[ Figure 1 about here]

We present estimates from the multilevel logistic regression models for COVID-19

vaccine intention in Table 2 To better illustrate overall COVID-19 vaccine intentions trajectories, Figure 1 shows the plotted predicted probabilities for vaccine intention from early April 2020 to January 2021.

Results from Figure 1 show that the probability of likely getting a COVID-19 vaccine was over 90% in early April but, by late July/August 2020 (wave 5), the probability decreased by 16%. By late October/November 2020 (wave 8), we also observe that the probability of likely getting a vaccine dropped by another six percentage points, but as the U.S. transitioned into 2021, intentions to receive a COVID-19 vaccine increased slightly. Results from model 1 in table 2 also show significant differences in COVID-19 vaccine intentions by race and ethnicity. More specifically, when compared to Whites, the odds of likely getting a COVID-19 vaccine were lower for Black respondents and higher for Asian and Pacific Islanders at baseline. 

The U.S. is currently experiencing unprecedented rates of COVID-19 infections, hospitalizations, and deaths. As a result, scholars argue that widespread uptake of COVID-19

vaccines may be the most effective strategy to reduce COVID-19 related morbidity and mortality. However, an emerging body of research finds a sizable portion of the U.S. population is hesitant to receive COVID-19 vaccines, with notable differences across racial and ethnic lines. (Tyson et al., 2020) . Lack of confidence in government and government officials may also contribute to the overall vaccine trajectory patterns observed in this study (Evans and Hargittai, 2020) . According to a Kaiser Family Foundation report, more than half of U.S. adults do not trust the federal government to ensure the safety and efficacy of COVID-19 vaccines (Hamel et al., 2020) , which ties to broader patterns showing less than 20% of U.S. adults trust the federal government to do the right thing always or most of the time .

Online misinformation concerning vaccines' safety and efficacy may also partially explain the declines in vaccine intentions observed in this study. A recent study of approximately 100 million Facebook users found anti-vaccination clusters were dominant in network patches and heavily entangled in clusters of users with undecided stances on vaccines. In the same study, J o u r n a l P r e -p r o o f researchers also found anti-vaccination individuals form twice as many clusters as provaccination individuals, providing more opportunities for engagement and ultimately increasing their network centrality . Consequently, the authors forecast that antivaccination views will dominate the platform within ten years without proper interventions.

This study also draws on literatures that highlight inequities in vaccine intention and vaccine uptake across racial and ethnic background. Our analysis shows significant differences in vaccine intentions by racial and ethnic background at the onset of the COVID-19 pandemic.

More specifically, in April of 2020, Black Americans had the lowest probability of likely getting a COVID-19 vaccination, while Asian/Pacific Islanders had the highest probability of getting a vaccination. Moreover, while the gap in COVID-19 vaccine intentions between Black Americans and other racial groups was substantial at the onset of the pandemic, results demonstrate the gap between Black Americans and other racial groups widened over time in most cases. Our finding that there is a substantial gap in vaccine intentions is consistent with a broad body of literature on racial and ethnic disparities in vaccine hesitancy and vaccine uptake. However, this is the first study to document that the gap between Black Americans and other racial groups may be widening as the U.S. continues to move through the COVID-19 pandemic.

Americans and other racial groups is trust. Studies find that if people do not trust the sources of information concerning vaccine efficacy and safety, they are likely to be vaccine-hesitant (Brownlie and Howson, 2005; Goldenberg, 2016; Yaqub et al., 2014) . As discussed previously, medical racism in the U.S. is deep and pervasive, disproportionately impacting Black communities both historically and presently. Evidence of contemporary medical racism has also been documented in recent reports that show almost 7 out 10 Black Americans believe patients are treated unfairly in medical settings due to their race and ethnicity (Kaiser Family Foundation 2020). This is coupled with the fact that during the time of this study, Black Americans reported Given these realities, Black Americans must grapple with the complex relationship between racism and mistrust when considering whether to get the COVID-19 vaccine when eligible (Harris et al. 2006) . Moreover, the pace at which vaccines have been developed, approved, and disseminated has left little time to address concerns related to vaccine efficacy and safety within Black communities. Therefore, the growing gap in vaccine intentions between Black Americans and other racial groups may be due to differential exposures to medical racism, both historically and presently, the lack of trust in government and health institutions, and the pace at which vaccines have been developed, tested, and distributed.

Black Americans and other racial and ethnic groups, scholars and health professionals argue that we must move beyond traditional vaccine public education campaigns designed to increase vaccine uptake. More specifically, health experts (e.g. South, 2021) Calarco et al. 2020; Hearne and Niño, 2021; Moen et al., 2020) . Given that structurally racist and sexist systems, in conjunction with socioeconomic drivers, may be jointly shaping vaccine intention patterns, future research would benefit from adopting an intersectional framework when examining race/ethnicity-COVID-19 vaccine intention trajectories.

J o u r n a l P r e -p r o o f 

Racial differences in the treatment of early-stage lung cancer

Leaps of faith'and MMR: an empirical study of trust

My Husband Thinks I'm Crazy': COVID-19-Related Conflict in Couples with Young Children. SocArXiv. October 9

Demographic differences in U.S. adult intentions to receive a potential coronavirus vaccine and implications for ongoing study

2020. Health Equity Considerations and Racial and Ethnic Minority Groups

Infant mortality in the United States, 2017: data from the period linked birth/infant death file

A strategic approach to COVID-19 vaccine R&D

Black doctors explain how to overcome reluctance toward the COVID vaccine

Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study

Public trust in government remains near historic lows as partisan attitudes shift

Vaccine hesitancy: an overview

Who Doesn't Trust Fauci? The Public's Belief in the Expertise and Shared Values of Scientists in the COVID-19 Pandemic

Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias

Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults

It's more than just news: Print media, the Tuskegee Syphilis Study and Collective Memory among African Americans

Determinants of trust in the flu vaccine for African Americans and Whites

Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic

Public misunderstanding of science? Reframing the problem of vaccine hesitancy

Sojourner. Physician-patient racial concordance and disparities in birthing mortality for newborns

Willingness to get the COVID-19 vaccine with and without emergency use authorization

The effects of racial attitudes on affect and engagement in racially discordant medical interactions between non-Black physicians and Black patients

KFF Health Tracking Poll

Barriers to pneumococcal and influenza vaccinations in Black elderly communities: mistrust

A National Survey Assessing SARS-CoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts

Understanding How Race, Ethnicity, and Gender Shape Mask-Wearing Adherence During the COVID-19 Pandemic: Evidence from the COVID Impact Survey

Trends in influenza vaccination coverage rates in Germany over five seasons from

Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles

Towards a more inclusive and dynamic understanding of medical mistrust informed by science

You don't trust a government vaccine": Narratives of institutional trust and influenza vaccination among African American and white adults

The online competition between pro-and antivaccination views

Herd immunity-estimating the level required to halt the COVID-19 epidemics in affected countries

Addressing the vaccine confidence gap

Vaccine hesitancy: Definition, scope and determinants

Racial and ethnic differences in access to medical care

Disparate disruptions: Intersectional COVID-19 employment effects by age, gender, education, and race/ethnicity. Work, aging and retire

Birthing justice: Black women, pregnancy, and childbirth

Simply put: Vaccination saves lives

Determinants of influenza vaccination among high-risk Black and White adults

Herd immunity: understanding COVID-19

Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated

International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples

Evidence of social and structural COVID-19 disparities by sexual orientation, gender identity, and race/ethnicity in an urban environment

Measles resurgence in the USA: how international travel compounds vaccine resistance

The effect of race and sex on physicians' recommendations for cardiac catheterization

Assembling a global vaccine development pipeline for infectious diseases in the developing world

COVID-19 vaccine development and a potential nanomaterial path forward

2021. I'm a Black doctor who didn't trust the COVID vaccine. Here's what changed my mind. NBC News

Influenza vaccine hesitancy in a low-income community in central New York State

Human papillomavirus vaccination: what are the reasons for nonvaccination among U.S. adolescents?

Public now divided over whether to get COVID-19 Vaccine

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Ten threats to global health in 2019

Attitudes to vaccination: a critical review